A Study of Mezigdomide in Healthy Participants and Participants With Hepatic Impairment

NCT05707390 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Impairment

Interventions

DRUG: Mezigdomide

Sponsor

Bristol-Myers Squibb